Adaptive Biotechnologies CEO on the company's IPO and pipeline

Chad Robins, CEO and co-founder of Adaptive Biotechnologies, joins "Squawk Box" ahead of his company's IPO on the Nasdaq. The life sciences and clinical diagnostic company could become the biggest biotech listing of 2019.